EC approves new Xaluprine formulation
December 12, 2012Research and Development
The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl …
First CCGs get green light
December 11, 2012Sales and Marketing CB, CCGs, Hunt, Lansley, NHS
In a landmark development for the controversial Health and Social Care Act, the first clinical commissioning groups (CCGs) have taken …
USP postpones work on elemental impurities
December 11, 2012Manufacturing and Production
The US Pharmacopeial Convention (USP) has postponed the publication of new chapters on elemental impurities after an appeal by drugmakers …
Boehringer to make cancer antibody for Apexigen
December 11, 2012Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer
Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …
EMA sets out stall on medicine shortages
December 11, 2012Manufacturing and Production EMA, GMP, shortages
The European Medicines Agency has called for action at the EU level to tackle the issue of medicine shortages caused …
Pharma manufacturing news in brief
December 11, 2012Manufacturing and Production AMRI, Hovione, NextPharma Tech, Recipharm, Sanner, Solvias
AMRI renews a key contract with GE, NextPharma sells off US unit Bioserv, plus facility updates for Sanner and Recipharm …
Pharma applauds government strategy
December 11, 2012Sales and Marketing ABPI, BIA, Cameron, Willetts
The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …
Perjeta reduces risk of death
December 11, 2012Sales and Marketing Cancer, Perjeta, Roche
Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …
Life Healthcare adds three heads to its team
December 11, 2012Medical Communications, Sales and Marketing Life Healthcare
Comms agency Life Healthcare Communications has added Steve Lewis, Helen Gillingham and Rosie Hider to its creative output.
Growth in GP drug prescriptions
December 11, 2012Sales and Marketing GPs, NHS, UK, doctors, prescribing
The volume of GP-prescribed drugs grew by an annual average of 8.4% in the years 1995-2010, according to new government …
Alzheimer’s drug lowers mortality
December 7, 2012Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly
A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …
Add value, pharma urged
December 7, 2012Medical Communications, Sales and Marketing ABPI, CCGs, NHS, Pharmafocus, Prescriber
Pharma will only form lasting relationships with the NHS in future by demonstrating its value, according to Kevin Blakemore, NHS …
Working Life: Caroline Horwood
December 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life
How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …
Circassia appoints new head to its Board of directors
December 6, 2012Manufacturing and Production, Research and Development, Sales and Marketing Circassia
Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
Protein Sciences builds flu vaccine facility
December 6, 2012Manufacturing and Production FDA, Protein
US drugmaker Protein Sciences has taken over a manufacturing facility formerly owned by Pfizer’s Wyeth unit as it prepares for …
‘Open door’ for pharma
December 6, 2012Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK
The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …
‘Risk share’ with us, say CCGs
December 6, 2012Sales and Marketing CCGs, NHS, Pharmafocus, Prescriber, pharma
Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …
uniQure appoints Basilea’s chief commercial officer
December 6, 2012Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure
Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
ImmunoCellular appoints Andrew Gengos as chief executive
December 5, 2012Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular
Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …
New boost for drug candidates
December 5, 2012Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden
A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
